XRP’s Future Hinges on a New Law, Not Charts
A Week of Gains Amidst Years-Long Low
XRP has clawed back 8% in the last week, but at $1.43, it remains 61% below its July 2025 peak of $3.65. The token’s recovery is tepid even as a wave of U.S. spot ETFs dedicated to XRP pull in staggering investor confidence.
ETFs Defy Token’s Price Decline: $1.44 Billion Inflows Since 2025 Launch
Despite XRP’s stagnant valuation, seven spot ETFs have amassed $1.44 billion in fresh capital since their late-2025 debut. These funds now manage nearly $1 billion—down from January’s $1.65 billion, but the drop stems from XRP’s price decline, not investor exits. The ETFs have enjoyed 35 consecutive days of net inflows, a streak unmatched by early Bitcoin or Ethereum spot funds.
Who’s Betting Big on XRP ETFs?
- Canary Capital’s XRPC: $260 million (largest holding)
- Bitwise: $257 million
- Franklin Templeton’s XRPZ: $211 million
- Goldman Sachs: $154 million spread across four funds
Yet, 84% of assets remain in retail hands, signaling institutional hesitance.
Institutional Interest Grows—But Regulatory Risks Loom
A Coinbase and EY-Parthenon survey of 351 institutional investors reveals:
- 18% already hold XRP.
- 25% plan to enter in 2026.
Their timing hinges on U.S. legislation.
The CLARITY Act: XRP’s Regulatory Crossroads
Passed by the House in July 2025 but stalled in the Senate, the CLARITY Act aims to establish a definitive crypto regulatory framework. Its passage in April 2026 could trigger institutional buying, lifting XRP above key resistance levels. A delay until 2027? Expect stagnation.
Why the SEC’s "Digital Commodity" Label Isn’t Enough
March 2026’s SEC/CFTC classification of XRP as a "digital commodity" is interpretive—legally shaky. Pension funds, endowments, and sovereign wealth funds avoid assets without ironclad legal status. The CLARITY Act’s resolution is critical.
Mixed Signals: Hold or Watch?
The ETF inflows are real but modest—far from the $10 billion needed to shift market dynamics. Until regulatory clarity or a sustained breakout emerges, the stance remains:
Neither a clear buy nor an outright sell—just a cautious hold.
